Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard K. Rosenberg
Richard K. Rosenberg
Lung cancer
Medicine
Respiratory disease
Oral administration
Vinorelbine
2
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer
2016
Investigational New Drugs
Giorgio V. Scagliotti
Jin-Hyoung Kang
David W. Smith
Richard K. Rosenberg
Keunchil Park
Sang-We Kim
Wu Chou Su
Thomas E. Boyd
Donald A. Richards
Silvia Novello
Scott M. Hynes
Scott P. Myrand
Ji Lin
Emily Nash Smyth
Sameera R. Wijayawardana
Aimee Bence Lin
Mary Pinder-Schenck
Show All
Source
Cite
Save
Citations (39)
Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
1995
Journal of Clinical Oncology
Everett E. Vokes
Richard K. Rosenberg
Mohammad Jahanzeb
Johnny B. Craig
Richard J. Gralla
Chandra P. Belani
Stephen E. Jones
Joseph Bigley
John A. Hohneker
Show All
Source
Cite
Save
Citations (42)
1